The strength of this study is that it is the first pilot study to demonstrate that rapamycin significantly modulates the polarisation of CD4+IFN-γ+ T (TH1) cells among T cell subsets in PBMC obtained from patients with active GPA/MPA. This evidence concerns the gene CD4 and granulomatosis with polyangiitis.